COGNITION THERAPEUTICS INC (CGTX) Stock Balance Sheet
NASDAQ:CGTX - Nasdaq - US19243B1026 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 22.01M | 29.92M | 41.56M | 54.72M | 5.19M | |||
| Receivables | 3.37M | 1.28M | 3.67M | 2.27M | 1.15M | |||
| Other Current Assets | 1.45M | 3.02M | 2.41M | 2.00M | 560.00K | |||
| Total Current Assets | 26.83M | 34.22M | 47.65M | 58.99M | 6.91M | |||
| Non-Current Assets | ||||||||
| PPE Net | 749.00K | 941.00K | 1.05M | 150.00K | 210.00K | |||
| Other Non-Current Assets | N/A | 0.00 | 1.73M | N/A | N/A | |||
| Total Non-Current Assets | 749.00K | 941.00K | 2.78M | 150.00K | 210.00K | |||
| TOTAL ASSETS | 27.58M | 35.16M | 50.43M | 59.14M | 7.12M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 9.69M | 4.23M | 2.24M | 1.75M | 990.00K | |||
| Accounts Payable | 1.90M | 3.69M | 3.22M | 4.17M | 2.00M | |||
| Other Current Liabilities | 1.12M | 2.25M | 2.34M | 1.95M | 250.00K | |||
| Total Current Liabilities | 12.71M | 10.17M | 7.80M | 7.86M | 3.25M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 12.85M | |||
| Other Non-Current Liabilities | 392.00K | 520.00K | 2.38M | 0.00 | 3.83M | |||
| Total Non-Current Liabilities | 392.00K | 520.00K | 2.38M | 0.00 | 16.68M | |||
| TOTAL LIABILITIES | 13.10M | 10.69M | 10.18M | 7.86M | 19.93M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -167.32M | -141.19M | -115.40M | -94.00M | -68.22M | |||
| Additional Paid In Capital | 181.76M | 165.83M | 155.82M | 145.45M | 220.00K | |||
| Common Shares | 41.00K | 32.00K | 30.00K | 20.00K | 55.37M | |||
| Other Shareholders' Equity | 0.00 | -195.00K | -200.00K | -200.00K | -190.00K | |||
| Shares Outstanding | 40.81M | 32.17M | 28.99M | 22.23M | 20.95M | |||
| Tangible Book Value per Share | 0.35 | 0.76 | 1.39 | 2.31 | -3.25 | |||
| Total Shareholders' Equity | 14.48M | 24.47M | 40.25M | 51.27M | -12.81M | |||
| TOTAL LIABILITIES AND EQUITY | 27.58M | 35.16M | 50.43M | 59.14M | 7.12M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | -1.00 | |||
| Current Ratio | 2.11 | 3.37 | 6.11 | 7.51 | 2.13 | |||
| Return On Assets (ROA) | -124.26% | -73.34% | -42.44% | -27.48% | -169.52% | |||
| Return On Equity (ROE) | -236.64% | -105.37% | -53.17% | -31.69% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21